MBX Biosciences, Inc.·4

Oct 20, 4:44 PM ET

Hoerter Steven L. 4

4 · MBX Biosciences, Inc. · Filed Oct 20, 2025

Insider Transaction Report

Form 4
Period: 2025-10-17
Transactions
  • Purchase

    Common Stock

    2025-10-17$13.25/sh+20,000$264,98420,000 total(indirect: By Trust)
Footnotes (1)
  • [F1]Shares held by the Steven L Hoerter Revocable Trust dated November 2, 2018, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4